This is a randomized, double-blind, placebo-controlled study to test whether a medication
called galantamine (Brand Name: Razadyne) will help smokers quit and whether it reduces
cognitive problems that smokers experience during a quit attempt.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
National Cancer Institute (NCI) National Center for Research Resources (NCRR) National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH)